Table 2 Event rates.

From: The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study

 

Incidence rate per 100 py (95%CI)

N (%)

Death

0.47 (0.27, 0.76)

16 (< 1%)

Hospitalization

11.88 (10.76, 13.1)

408 (11.9%)

Respiratory

4.46 (3.78, 5.22)

153 (4.5%)

GI

1.46 (1.08, 1.92)

50 (1.5%)

Mental hospitalization

0.06 (0.01, 0.21)

2 (< 1%)

CV hospitalization

0.32 (0.16–0.57)

11 (< 1%)

Medication

 Non-opioid analgesic

19.63 (18.18, 21.17)

674 (19.6%)

 NSAID

7.78 (6.87, 8.77)

267 (7.8%)

 Antiplatelet

0.06 (0.01, 0.21)

2 (< 1%)

 ACEi

4.98 (4.26, 5.79)

171 (5.0%)

 ARB

5.56 (4.8, 6.41)

191 (5.6%)

 Aspirin

5.48 (4.72, 6.32)

188 (5.5%)

 BB

6.32 (5.51, 7.22)

217 (6.3%)

 CCB

15.38 (14.1, 16.75)

528 (15.4%)

 Thiazide diuretics

0.58 (0.36, 0.9)

20 (< 1%)

 Other diuretics

1.81 (1.38, 2.32)

62 (1.8%)

 Statin

13.11 (11.92, 14.38)

450 (13.1%)

 Anti-depressants

3.47 (2.87, 4.15)

119 (3.5%)

  1. ACEI ACE-inhibitor, AF atrial fibrillation, ARB angiotensin receptor II blocker, BB beta-blocker, CCB calcium channel blocker, CV cardiovascular, GI gastro-intestinal.
Back to article page